COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 184 filers reported holding COHERUS BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $268,000 | -43.9% | 37,000 | 0.0% | 0.02% | -61.3% |
| Q1 2022 | $478,000 | -19.1% | 37,000 | 0.0% | 0.06% | -25.3% |
| Q4 2021 | $591,000 | -0.7% | 37,000 | 0.0% | 0.08% | -18.6% |
| Q3 2021 | $595,000 | +16.2% | 37,000 | 0.0% | 0.10% | -8.9% |
| Q2 2021 | $512,000 | -5.4% | 37,000 | 0.0% | 0.11% | -20.6% |
| Q1 2021 | $541,000 | -22.2% | 37,000 | -7.5% | 0.14% | -38.4% |
| Q4 2020 | $695,000 | -45.9% | 40,000 | -42.9% | 0.23% | -21.0% |
| Q3 2020 | $1,284,000 | -36.0% | 70,000 | -37.7% | 0.29% | -35.8% |
| Q2 2020 | $2,007,000 | +5.4% | 112,385 | -4.3% | 0.45% | +25.6% |
| Q1 2020 | $1,904,000 | -15.3% | 117,385 | -6.0% | 0.36% | +110.5% |
| Q4 2019 | $2,247,000 | -11.2% | 124,825 | 0.0% | 0.17% | +8.2% |
| Q3 2019 | $2,529,000 | – | 124,825 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
| CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
| AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
| Knott David M Jr | 630,000 | $2,356 | 0.90% |
| COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
| Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
| Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
| Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
| Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |